A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran

Zamani, Saman; Farnia, Marziyeh; Tavakoli, Sina; Gholizadeh, Mehran; Nazari, Mohammad Ali; Seddighi, Ali-Akbar; Setayesh, Hamidreza; Afshar, Parviz; Kihara, Masahiro

doi:10.1016/j.drugpo.2009.03.001

Cited by 35 publications

(46 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The inflated price for all three drug preparations in prison relative to the community that we found from our survey have also been reported for heroin in Iran (Zamani et al, 2010). Despite the increased availability of prescribed methadone in prison it is perceived as being significantly harder to sell in prison than both buprenorphine and buprenorphine/naloxone.…”

Section: Discussionsupporting

confidence: 69%

Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners

Wright¹,

Mohammed²,

Hughes³

2014

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 69%

Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners

Wright¹,

Mohammed²,

Hughes³

2014

Drug and Alcohol Dependence

View full text Add to dashboard Cite

“…Our study indicated that approximately 70% of participants had a history of imprisonment, of which more than onefifth shared needles while in prison. Since 2005, harmreduction interventions inside Iranian prisons have been expanded; however, only one qualitative study has reported a significant decrease in injection drug use in one prison (32). We found that drug injection frequency of more than once per day and drug use duration of more than 10 years were associated with high rates of HCV infection.…”

Section: Variables Correlated With Hepatitis Cmentioning

confidence: 63%

Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

et al. 2012

View full text Add to dashboard Cite

This article presents that IDUs are highly at risk of hepatitis B and C virus infections. This has an important implication for those who are involved in planning for providing harm reduction services, especially in prison settings. Background:In Iran, the number of injecting drug users (IDUs) has increased in recent years. The rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections among IDUs are reportedly high. Objectives: The purpose of this study was to assess factors correlated with HCV and HBV infections among IDUs in Tehran. Patients and Methods: A cross-sectional study included 899 IDUs recruited from the community, drug treatment centers, and drop-in-centers. The study involved interviews conducted using an adapted version of the WHO Drug Injection Study Phase II (Version 2b) questionnaire and blood testing for the HCV antibody, hepatitis B surface antigen, and hepatitis B core antibody. A logistic regression model was used to identify independent factors correlated with HCV and HBV infections. Results: HCV infection was found to be primarily associated with female gender [odds ratio (OR) 5.0, 95% confidence interval (CI) 2.0-10.0)], unmarried status (OR 2.9, 95% CI 1.9-4.4), drug use for more than 10 years (OR 2.7, 95% CI 1.8-3.9), drug injection frequency of more than once per day (OR 2.6, 95% CI 1.6-4.2), history of imprisonment (OR 2.5, 95% CI 1.6-4.0)], and a history of shared injection needles in prison (OR 2.3, 95% CI 1.5-3.6). HBV infection was mainly correlated with a history of imprisonment (OR 1.9, 95% CI 1.4-2.7) and drug use for more than 10 years (OR 1.4, 95% CI 1.1-1.9). Conclusions: Because a considerable number of IDUs in Iran are receiving reduction services, tailoring services for prevention of hepatitis infection are necessary.

show abstract

“…Among other interventions implemented in Iran are drop-in centers, integration of substance use treatment and HIV prevention into the rural primary health care system, and community education centers [62],[101]–[105]. These efforts appear to have been successful in reducing sharing of injecting equipment [106]–[108], though the coverage of harm reduction continues to be lower than adequate [104].…”

Section: Discussionmentioning

confidence: 99%

HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis

et al. 2014

Self Cite

View full text Add to dashboard Cite

show abstract

A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran

Cited by 35 publications

References 14 publications

Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners

Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners

Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis

Contact Info

Product

Resources

About